MPWT
ALXN

MassMutual Private Wealth & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-127
Closed -$23K – 1379
2021
Q2 		$23K Buy
127
+78
+159% +$13.4K ﹤0.01% 561
2021
Q1 		$7K Buy
+49
New +$7.58K ﹤0.01% 671
2018
Q3 		– Sell
-50
Closed -$6.21K – 1148
2018
Q2 		$6.21K Sell
50
-17
-25% -$1.99K ﹤0.01% 683
2018
Q1 		$7.47K Buy
+67
New +$8.01K ﹤0.01% 647
2016
Q2 		– Hold
0
– – – 1036
2016
Q1 		– Sell
-35
Closed -$5.14K – 973
2015
Q4 		$6.68K Buy
+35
New +$6.11K ﹤0.01% 533

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return